Karla Thatcher Rojas
Research Subjects
Research Interests
Karla Thatcher Rojas has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Aly Azeem Khan
University of Chicago
1 shared publication Bali Pulendran
Emory Vaccine Center, Emory University, Atlanta, Georgia, USA
1 shared publication- Carole Henry
Department of Medicine, Section of Rheumatology, University of Chicago, Chicago, IL 60637, USA
1 shared publication Charles L. Dulberger
The Department of Biochemistry and Molecular Biophysics, The University of Chicago, Chicago, Illinois, USA
1 shared publication- Dustin G. Shaw
University of Chicago Department of Medicine, Section of Rheumatology 4 , Chicago, IL
1 shared publication Jenna J. Guthmiller
The Department of Medicine, Section of Rheumatology
1 shared publication
Latest Publications
- 19 November 2018
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 129 (1) , 93-105
Spec-seq unveils transcriptional subpopulations of antibody-secreting cells following influenza vaccination
Vaccines are among the most effective public health tools for combating certain infectious diseases such as influenza. The role of the humoral immune system in vaccine-induced protection is widely appreciated; however, our understanding of how antibody specificities relate to B cell function remains limited due to the complexity of polyclonal antibody responses. To address this, we developed the Spec-seq framework, which allows for simultaneous monoclonal antibody (mAb) characterization and transcriptional profiling from the same single cell. Here, we present the first application of the Spec-seq framework, which we applied to human plasmablasts after influenza vaccination in order to characterize transcriptional differences governed by B cell receptor (BCR) isotype and vaccine reactivity. Our analysis did not find evidence of long-term transcriptional specialization between plasmablasts of different isotypes. However, we did find enhanced transcriptional similarity between clonally related B cells, as well as distinct transcriptional signatures ascribed by BCR vaccine recognition. These data suggest IgG and IgA vaccine–positive plasmablasts are largely similar, whereas IgA vaccine–negative cells appear to be transcriptionally distinct from conventional, terminally differentiated, antigen-induced peripheral blood plasmablasts.
- 19 November 2018
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 129 (1) , 93-105
Spec-seq unveils transcriptional subpopulations of antibody-secreting cells following influenza vaccination
Vaccines are among the most effective public health tools for combating certain infectious diseases such as influenza. The role of the humoral immune system in vaccine-induced protection is widely appreciated; however, our understanding of how antibody specificities relate to B cell function remains limited due to the complexity of polyclonal antibody responses. To address this, we developed the Spec-seq framework, which allows for simultaneous monoclonal antibody (mAb) characterization and transcriptional profiling from the same single cell. Here, we present the first application of the Spec-seq framework, which we applied to human plasmablasts after influenza vaccination in order to characterize transcriptional differences governed by B cell receptor (BCR) isotype and vaccine reactivity. Our analysis did not find evidence of long-term transcriptional specialization between plasmablasts of different isotypes. However, we did find enhanced transcriptional similarity between clonally related B cells, as well as distinct transcriptional signatures ascribed by BCR vaccine recognition. These data suggest IgG and IgA vaccine–positive plasmablasts are largely similar, whereas IgA vaccine–negative cells appear to be transcriptionally distinct from conventional, terminally differentiated, antigen-induced peripheral blood plasmablasts.